Search research articles
Contact Us
Filters
Showing results (11-20 of 57) with videos related to
Page
of 6
Sort By:
Medicine and Health, Rhode Island
|
August 19, 2008
Rituximab in treating refractory thrombotic thrombocytopenic purpura: three case reports
Samir Dalia, Brendan McNulty, Gerald A Colvin
Annals of Translational Medicine
|
January 9, 2023
Non-small cell lung cancer with MET exon 14 skip mutation: case report
Wolfgang Clough, Mira Al Jaberi, Samir Dalia
Infectious Disorders Drug Targets
|
April 8, 2016
EBV-Related Malignancies, Outcomes and Novel Prevention Strategies
Oluwatobi Ohiole Ozoya, Lubomir Sokol, Samir Dalia
Journal of Clinical and Translational Hepatology
|
June 29, 2016
Hepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention Strategies
Oluwatobi O Ozoya, Lubomir Sokol, Samir Dalia
Oncotarget
|
May 26, 2023
Latest updates on <i>MET</i> targeted therapy for EXON 14 mutations in lung cancer
Mira Al Jaberi, Wolfgang Clough, Samir Dalia
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2011
Meta-analysis of the association between cigarette smoking and incidence of Hodgkin's Lymphoma
Jorge J Castillo, Samir Dalia, Helen Shum
Leukemia Research
|
September 24, 2015
Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies
Samir Dalia, Kelli Dunker, Lubomir Sokol, et al.
Drugs in Context
|
October 25, 2019
Venetoclax: evidence to date and clinical potential
Luis Miguel Juárez-Salcedo, Viraj Desai, Samir Dalia
Current Cancer Drug Targets
|
October 31, 2015
A New Therapeutic Era in GCB and ABC Diffuse Large B-cell Lymphoma Molecular Subtypes: A Cell of Origin-Driven Review
Jose D Sandoval-Sus, Julio Chavez, Samir Dalia
Cancer Control : Journal of the Moffitt Cancer Center
|
October 14, 2014
Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment
Samir Dalia, Elizabeth Sagatys, Lubomir Sokol, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 57) with videos related to
Sort By:
Page
of 6
Medicine and Health, Rhode Island
|
August 19, 2008
Rituximab in treating refractory thrombotic thrombocytopenic purpura: three case reports
Samir Dalia, Brendan McNulty, Gerald A Colvin
Annals of Translational Medicine
|
January 9, 2023
Non-small cell lung cancer with MET exon 14 skip mutation: case report
Wolfgang Clough, Mira Al Jaberi, Samir Dalia
Infectious Disorders Drug Targets
|
April 8, 2016
EBV-Related Malignancies, Outcomes and Novel Prevention Strategies
Oluwatobi Ohiole Ozoya, Lubomir Sokol, Samir Dalia
Journal of Clinical and Translational Hepatology
|
June 29, 2016
Hepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention Strategies
Oluwatobi O Ozoya, Lubomir Sokol, Samir Dalia
Oncotarget
|
May 26, 2023
Latest updates on <i>MET</i> targeted therapy for EXON 14 mutations in lung cancer
Mira Al Jaberi, Wolfgang Clough, Samir Dalia
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2011
Meta-analysis of the association between cigarette smoking and incidence of Hodgkin's Lymphoma
Jorge J Castillo, Samir Dalia, Helen Shum
Leukemia Research
|
September 24, 2015
Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies
Samir Dalia, Kelli Dunker, Lubomir Sokol, et al.
Drugs in Context
|
October 25, 2019
Venetoclax: evidence to date and clinical potential
Luis Miguel Juárez-Salcedo, Viraj Desai, Samir Dalia
Current Cancer Drug Targets
|
October 31, 2015
A New Therapeutic Era in GCB and ABC Diffuse Large B-cell Lymphoma Molecular Subtypes: A Cell of Origin-Driven Review
Jose D Sandoval-Sus, Julio Chavez, Samir Dalia
Cancer Control : Journal of the Moffitt Cancer Center
|
October 14, 2014
Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment
Samir Dalia, Elizabeth Sagatys, Lubomir Sokol, et al.
Page
of 6